ArticleActa pharmaceutica Sinica. B2022

Combining immune checkpoint blockade with ATP-based immunogenic cell death amplifier for cancer chemo-immunotherapy.

Jiulong Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.